Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSP90 as Predictive Marker for HIPEC Response in Ovarian PC
NCT02803515Terminated
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Changes in serum levels of HSP90 and 70 on peripheral venous samples at Day 5. Started Jan 2017; status: terminated.
Beyond the preview
Go deeper on NCT02803515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02803515.